CKMT1A and nasopharyngeal carcinoma: CKMT1A can reduce the arrest of the G2/M phase cell cycle, enhance colony formation rates, lower the apoptosis rate and c-PARP level, and elevate STAT3 phosphorylation levels via CRISPR/Cas9 system in nasopharyngeal carcinoma [19].